N-Benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme
US4448781A · kind A · utility
24Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 1981 |
| Grant date | May 15, 1984 |
| Priority date | — |
| Expiry date | Jul 27, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The N-(substituted benzyl) imidazoles are selective enzyme inhibitors and thus are useful in the treatment of heart disease, circulatory and vascular problems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.